Novel echocardiographic pixel intensity quantification method for differentiating transthyretin cardiac amyloidosis from light chain cardiac amyloidosis and other phenocopies
View abstract on PubMed
Summary
This summary is machine-generated.A novel echocardiographic septal reflectivity ratio (SRR) effectively distinguishes transthyretin (ATTR)-cardiac amyloidosis (CA) from light chain (AL)-CA. This reproducible method aids in diagnosing ATTR-CA, guiding crucial treatment decisions.
Area Of Science
- Cardiology
- Medical Imaging
- Biophysics
Background
- Differentiating transthyretin (ATTR)-cardiac amyloidosis (CA) from light chain (AL)-CA is critical due to distinct therapeutic strategies.
- Accurate echocardiographic methods are needed to distinguish between CA subtypes and other forms of left ventricular hypertrophy.
Purpose Of The Study
- To assess a novel echocardiographic pixel intensity method, the septal reflectivity ratio (SRR), for quantifying myocardial calcification.
- To evaluate the SRR's accuracy in differentiating ATTR-CA from AL-CA and other cardiac conditions.
Main Methods
- Retrospective evaluation of 167 patients, including ATTR-CA, AL-CA, hypertrophic cardiomyopathy, and chronic kidney disease cohorts.
- Measurement of the septal reflectivity ratio (SRR) using pixel intensity of myocardial walls.
- Receiver operator characteristic (ROC) analysis to determine diagnostic accuracy.
Main Results
- Mean SRR was significantly higher in the ATTR-CA cohort compared to all other groups (P < 0.001).
- SRR demonstrated high accuracy in distinguishing ATTR-CA from other cohorts (AUC = 0.91) and specifically from AL-CA (AUC = 0.90, 96% specificity, 63% sensitivity).
- Excellent inter- and intra-operator reproducibility was confirmed (ICC = 0.91 and 0.89, respectively).
Conclusions
- The septal reflectivity ratio (SRR) is a reproducible and robust echocardiographic parameter.
- SRR effectively differentiates ATTR-cardiac amyloidosis from other cardiac conditions, including AL-cardiac amyloidosis.

